Last quarter (Q3 2023), DMK Pharmaceuticals's total revenue was $9.06K, a decrease of -99.40% from the same quarter last year. In Q3, DMK Pharmaceuticals's net income was $-1.74M. See DMK Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 3.53M	$ 4.76M	$ 2.21M	$ 2.78M	$ 22.11M	$ 15.09M
Cost of Revenue	$ -3.48M	$ 6.19M	$ 6.87M	$ 6.33M	$ 15.48M	$ 9.80M
Gross Profit	$ -1.35M	$ -1.43M	$ -4.66M	$ -3.55M	$ 6.64M	$ 5.29M
Operating Expense	$ 11.80M	$ 23.63M	$ 27.41M	$ 28.13M	$ 35.66M	$ 44.74M
Operating Income	$ -9.58M	$ -25.06M	$ -32.07M	$ -31.68M	$ -29.03M	$ -39.45M
Net Non Operating Interest Income Expense	$ -2.00M	$ 556.81K	$ 5.00M	$ -4.92K	$ -123.26K	$ 87.64K
Other Income Expense	$ -6.18M	$ 1.70M	$ 7.53M	$ -4.16M	$ 1.65M	$ -10.52K
Pretax Income	$ -21.16M	$ -26.20M	$ -34.60M	$ -35.84M	$ -27.50M	$ -39.38M
Tax Provision	$ 2.00K	$ 2.00K	$ 796.00	$ 2.40K	$ 8.67K	$ -369.34K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.82M	$ -26.48M	$ -45.83M	$ -49.39M	$ -27.51M	$ -39.01M
Basic EPS	$ -3.66	$ -0.17	-	$ -0.64	$ -0.55	$ -1.00
Diluted EPS	$ -3.66	$ -0.17	$ -5.60	$ -0.64	$ -0.55	$ -1.00
Basic Average Shares	$ 312.40M	$ 149.85M	$ 2.06M	$ 77.57M	$ 53.26M	$ 39.09M
Diluted Average Shares	$ 312.40M	$ 149.85M	$ 2.06M	$ 77.57M	$ 53.26M	$ 39.09M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 8.33M	$ 29.82M	$ 34.28M	$ 34.46M	$ 51.14M	$ 54.54M
Net Income From Continuing And Discontinued Operation	$ -22.23M	$ -26.48M	$ -45.83M	$ -49.39M	$ -27.51M	$ -39.01M
Normalized Income	$ -6.90M	-	-	$ -32.78M	$ -28.59M	$ -39.00M
Interest Expense	-	-	-	$ 4.92K	$ 123.26K	$ 157.76K
EBIT	$ -21.62M	$ -26.20M	$ -34.60M	$ -35.84M	$ -27.38M	$ -39.22M
EBITDA	$ -20.98M	$ -24.71M	$ -33.16M	$ -33.51M	$ -24.44M	$ -36.12M

Currency in USD

DMK Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing